New asthma inhaler shows promise in early trial
NCT ID NCT06644924
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested a single dose of a new albuterol inhaler called PT007 in 118 adults with asthma. Researchers compared how well it opened airways and its safety against a placebo inhaler and the standard Ventolin inhaler. The goal is to see if PT007 works as a quick-relief treatment for asthma symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Albuterol Sulfate (PT007 inhaler)
What this could lead to
If successful, PT007 could offer a new rescue inhaler option for asthma patients to quickly open airways during attacks.
What could go wrong
This is an early Phase 2 trial with only 118 participants, so results may not apply to everyone. The drug is similar to existing albuterol inhalers, so major breakthroughs are unlikely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Encinitas, California, 92024, United States
-
Research Site
Lancaster, California, 93534, United States
-
Research Site
Los Angeles, California, 90048, United States
-
Research Site
Newport Beach, California, 92663, United States
-
Research Site
San Diego, California, 92123, United States
-
Research Site
San Jose, California, 95117, United States
-
Research Site
Stockton, California, 95207, United States
-
Research Site
Clearwater, Florida, 33765, United States
-
Research Site
Miami, Florida, 33175, United States
-
Research Site
Tallahassee, Florida, 32308, United States
-
Research Site
Tampa, Florida, 33607, United States
-
Research Site
White Marsh, Maryland, 21162, United States
-
Research Site
Columbia, Missouri, 65203, United States
-
Research Site
Saint Charles, Missouri, 63301, United States
-
Research Site
St Louis, Missouri, 63141, United States
-
Research Site
Raleigh, North Carolina, 27607, United States
-
Research Site
Medford, Oregon, 97504, United States
-
Research Site
Portland, Oregon, 97202, United States
-
Research Site
Austin, Texas, 78759, United States
-
Research Site
El Paso, Texas, 79912, United States
-
Research Site
Victoria, Texas, 77901, United States
-
Research Site
Milwaukee, Wisconsin, 53228, United States